Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:acquiredBy |
gptkb:Pfizer
|
| gptkbp:acquisitionYear |
2015
|
| gptkbp:CEO |
gptkb:F._Michael_Ball
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:founded |
2004
spin-off from Abbott Laboratories |
| gptkbp:headquartersLocation |
gptkb:Lake_Forest,_Illinois,_United_States
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:GemStar_infusion_system
gptkb:Precedex gptkb:Propofol |
| gptkbp:numberOfEmployees |
approximately 19,000 (2015)
|
| gptkbp:parentCompany |
gptkb:Pfizer
|
| gptkbp:products |
biosimilars
generic injectable pharmaceuticals infusion technologies |
| gptkbp:stockSymbol |
gptkb:HSP
|
| gptkbp:tradedOn |
gptkb:NYSE
|
| gptkbp:website |
www.hospira.com
|
| gptkbp:bfsParent |
gptkb:Pfizer
gptkb:erythropoietin gptkb:Abbott |
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Hospira
|